Compare EXEL & AMKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXEL | AMKR |
|---|---|---|
| Founded | 1994 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 11.3B |
| IPO Year | 2000 | 1997 |
| Metric | EXEL | AMKR |
|---|---|---|
| Price | $41.26 | $42.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 9 |
| Target Price | $46.45 | ★ $52.88 |
| AVG Volume (30 Days) | 2.8M | ★ 4.1M |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 0.81% |
| EPS Growth | ★ 57.95 | 4.90 |
| EPS | ★ 2.78 | 1.50 |
| Revenue | $452,477,000.00 | ★ $4,052,650,000.00 |
| Revenue This Year | $13.66 | $13.21 |
| Revenue Next Year | $13.73 | $9.80 |
| P/E Ratio | ★ $14.80 | $27.49 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.38 | $14.03 |
| 52 Week High | $48.74 | $57.09 |
| Indicator | EXEL | AMKR |
|---|---|---|
| Relative Strength Index (RSI) | 42.55 | 42.64 |
| Support Level | $40.01 | $39.07 |
| Resistance Level | $44.15 | $47.28 |
| Average True Range (ATR) | 1.33 | 2.12 |
| MACD | -0.16 | -0.52 |
| Stochastic Oscillator | 26.06 | 22.21 |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Amkor Technology Inc is a OSAT (outsourced semiconductor assembly and test) service provider. It has pioneered the outsourcing of integrated circuit (IC) packaging and test services and is a strategic manufacturing partner for the semiconductor companies, foundries, and electronics original equipment manufacturers (OEMs). The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.